OUR SCIENCE

SMART DRUG DELIVERY PLATFORM BASED ON CELL-DERIVED VESICLES

Production process

CDVs are produced by a systematic extrusion and purification process from various human-derived cells, and they are used in discovery studies and non-clinical studies with domestic and global partners.

01
Technology transfer of our own extruder and production process to specialized overseas production organizations
02
First GMP production scheduled for the end of 2021
03
Mass production of additional cells planned from 2022